2015

Abnormalities associated with progressive aortic vascular dysfunction in chronic kidney disease

oaladhami, 719, Journal Article, , Abnormalities associated with progressive aortic vascular dysfunction in chronic kidney disease. (2015). Frontiers in Physiology 6, 150, 2015, 6(150).

2015

Validated HPLC method for simultaneous estimation of khellol glucoside, khellin and visnagin in Ammi visnaga L. fruits and pharmaceutical preparations.

kelnahriry, 1138, Journal Article, , Validated HPLC method for simultaneous estimation of khellol glucoside, khellin and visnagin in Ammi visnaga L. fruits and pharmaceutical preparations. (2015). Nat Prod Res., 29(7).

2014

Discovery of novel urokinase plasminogen activator (uPA) inhibitors using ligand-based modeling and virtual screening followed by in vitro analysis

mkhanfar, 645, Journal Article, , Discovery of novel urokinase plasminogen activator (uPA) inhibitors using ligand-based modeling and virtual screening followed by in vitro analysis. (2014). Journal of Molecular Modeling 20 (1), 1-15, 2014, 20, 2080.

2014

Sympathetic overactivity prevails over the vascular amplifier phenomena in a chronic kidney disease rat model of hypertension

oaladhami, 719, Journal Article, , Sympathetic overactivity prevails over the vascular amplifier phenomena in a chronic kidney disease rat model of hypertension. (2014). Physiological Reports 2 (11), E12205, 2014, 11(12205).

2014

Discovery of novel urokinase plasminogen activator (uPA) inhibitors using ligand-based modeling and virtual screening followed by in vitro analysis

mkhanfar, 645, Journal Article, , Discovery of novel urokinase plasminogen activator (uPA) inhibitors using ligand-based modeling and virtual screening followed by in vitro analysis. (2014). Journal of Molecular Modeling, 20, 2080.

2014

). Differential contribution of afferent and central pathways to the development of baroreflex dysfunction in chronic kidney disease

oaladhami, 719, Journal Article, , ). Differential contribution of afferent and central pathways to the development of baroreflex dysfunction in chronic kidney disease. (2014). Hypertension, 63, 804-810.

2014

Altered structural and biomechanical properties of mesenteric resistance arteries in a rat model of cystic kidney disease

oaladhami, 719, Journal Article, , Altered structural and biomechanical properties of mesenteric resistance arteries in a rat model of cystic kidney disease. (2014). Journal of Vascular Research 51 (Supplement 2), 115-115, 2014.

2014

Cardiovascular autonomic dysfunction in chronic kidney disease

isalman, 854, Journal Article, , Cardiovascular autonomic dysfunction in chronic kidney disease. (2014). Macquarie University, Faculty of Medicine and Health Sciences, Australian …, 2014.

2014

Development and characterization of 3-(benzylsulfonamido) benzamides as potent and selective SIRT2 inhibitors

mkhanfar, 645, Journal Article, , Development and characterization of 3-(benzylsulfonamido) benzamides as potent and selective SIRT2 inhibitors. (2014). European Journal of Medicinal Chemistry 76, 414-426, 2014, 76, 414–426.

2014

Opposing changes in thoracic and abdominal aortic biomechanical properties in rodent models of vascular calcification and hypertension

oaladhami, 719, Journal Article, , Opposing changes in thoracic and abdominal aortic biomechanical properties in rodent models of vascular calcification and hypertension. (2014). American Journal of Physiology-Heart and Circulatory Physiology, 307, H143–H151.